ArticleJournal of Cancer2020

Decision-making of Adjuvant Chemotherapy for Breast Cancer Patients with Discordant Risk Classifications between Clinical-Pathological Factors and 21-gene Recurrence Score.

Weiqi Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.